CLINICAL_TRIALS
trial_result
· 2020-09-14
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis [Phase 3]
Summary
Phase 3 trial evaluating FX006 for hip osteoarthritis was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis, Hip | Phase 3 | Status: TERMINATED | Results posted: 2020-09-14